R
Rheumazentrum Ratingen Studienambulanz | Ratingen, Germany
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tulisokibart
MK-7240
Baricitinib
LY3009104
LY3871801
MK-7240-014
MK-7240-013
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffn...
Enrolling
Radiographic Axial Spondyloarthritis
Drug: Placebo
Drug: Tulisokibart
Researchers are looking for new ways to treat rheumatoid arthritis (RA). Methotrexate (MTX) is a standard (usual) treatment for RA. However, MTX and...
Enrolling
Arthritis, Rheumatoid
Drug: Tulisokibart
Drug: Placebo
The main purpose of this study is to evaluate the efficacy and safety of LY3871801 in adult participants with active moderately-to-severe rheumatoid...
Enrolling
Rheumatoid Arthritis
Drug: LY3871801
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems